Pfizer bought G...
login
Shares
Bonds
Calendar
Dividends
Portfolio
More
ETF
Sectors
News
Pre-IPO
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Global Blood Therapeutics
Pfizer bought Global Blood Therapeutics
10/5/22 at 16:56
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.
Global Blood Therapeutics
Review
Source:
investors.pfizer.com
Vladimir Petenev
News editor
Share at:
Share this news
×
News feed
Ivan Potapov has been appointed General Director of the MMCB
Yesterday at 18:46
GEMA
Ozon to launch DFA platform
Yesterday at 17:12
OZON
Ozon Pharmaceuticals expands the range of the Immunotresan drug
Yesterday at 15:12
OZPH
En+ Group to build in Siberia 1 GW thermal power plant
Yesterday at 11:22
ENPG
China has refused to import electricity from Russia
Yesterday at 10:09
IRAO
Sollers launches sales of new bus Sollers SA6
1/15/26
SVAV
EBITDA of Eurotrans increased by the end of 2025 by 40%
1/15/26
EUTR
Board of Directors of Mosenergo recommended that dividends be paid for 2024
1/15/26
MSNG
Volume of sales of APRI in December increased by 2.3 times
1/15/26
APRI
Rostelecom acquired 49% of Polymatika Rus company
1/15/26
RTKM
«
Previous
1
2
3
4
5
6
7
8
9
10
»
Next
BlackTerminal.com 2016 - 2026.
English (US)
English (US)
Русский (РФ)
investors.pfizer.com
English (US) 